Webinar: The Life of a Drug Test

by Pablo Bolanos on November 28, 2017

From the perspective of an employer, the drug testing process is an in-and-out experience. A potential new hire or current employee provides a sample at one of our collection sites. Days later—after the sample is sent to the laboratory for testing—a final result is ready. At which point the employee returns to work or, a job candidate can start their new job.

Every year, millions of drug test specimens pass through our laboratories, taking an intricate journey from collection to result. We carefully crafted the entire process to be simple and without complications. Each specimen is ushered through by sophisticated, state-of-the-art instrumentation, time-tested processes, and a village of trained collectors and laboratory professionals who adhere to strict, highly regulated processes and procedures.

In our upcoming webinar, the life of a drug test, Quest experts, Dawn Hahn, Director of Laboratory Operations, and David Bustos, Collection Services Manager, will give you a behind-the-scenes look at the drug testing process from, the perspectives of a scientist and a collector, to boost your drug testing IQ. Topics include:

  • What to expect at a collection site
  • Drug test specimen-logistics
  • Specimen processing and testing at the lab
  • Quality control
  • Chain of custody standards

Register now to join us on Wednesday, December 13 at 1 p.m. CT.

To learn more about drug testing, visit our website or contact us online.

Weeding Out the Facts Webinar Recap

by Nicole Jupe on February 21, 2017

Employers face challenges as states continue to pass marijuana legislation, while the substance is still illegal under federal law.  In our recent webinar, two highly-regarded industry experts, Dr. Barry Sample, Senior Director of Science and Technology, Quest Diagnostics, and D. Faye Caldwell, Attorney at Law, Caldwell Everson, presented facts and insight about marijuana and the workplace for both the scientific and legal landscapes.

Some key takeaways from our webinar include:

  • Data indicated that marijuana use in general society is up. The increase is primarily driven by use among adults ages 26 years or older, according to data from the National Survey on Drug Use and Health (NSDUH). Self-reported marijuana use in the employment sector is also increasing.
  • According the latest Quest Diagnostics Drug Testing Index™ report, nearly half (45 percent) of individuals in the general U.S. workforce with a positive drug test for any substance showed evidence of marijuana.
  • Research studies have shown that marijuana use can be impairing and can impact reaction times, concentration, task performance, and driving.
  • Twenty-nine states and D.C. have medical marijuana laws.
  • An additional fifteen states have low THC/high CBD (cannabidiol) laws for limited medical purposes, but the allowable levels of THC in the oils fluctuate (between none and up to 5%) by state.
  • There is limited research on the benefits of medical marijuana, although some funding has been allocated to study how marijuana impacts certain medical conditions.
  • In addition to the existing qualifying conditions in medical marijuana laws, a number of states have considered adding post-traumatic stress disorder (PTSD), chronic pain, and substance abuse disorders as qualifying conditions for medical marijuana.
  • Marijuana laws are inconsistent and constantly changing. The laws can impact company drug testing policies and procedures, drug testing program administration, and how drug test results are handled.
  • Employment protections in current marijuana laws vary widely by state – ranging from explicitly providing no protections to being unclear to providing explicit protections – and employers may have a duty to accommodate off-duty usage. Most explicit employment protection laws have no exemption for “safety-sensitive” employees.
  • Eight states with medical marijuana have also passed recreational use laws, one of which has explicit employee protections.
  • “All of these medical and recreational use statutes probably impact only a very small number of employees at most employer locations,” said Dr. Sample.
  • Quest data shows that more than 99 percent of all urine workplace drug tests in the United States continue to include marijuana as a part of the drug testing panel despite state marijuana legislation.
  • A clearly written drug testing policy that complies with local and state laws remains paramount. The policy should detail who is tested, what drug test specimen type is used, and the consequences of a violation. Inform employees of the policy and consistently apply it across the entire workforce.

In conclusion, there are currently no restrictions on testing for marijuana. Furthermore, the current laws do not require an employer to accommodate on-duty drug use in the workplace or prohibit an employer from taking action if an employee is working under the influence of marijuana.

Based on the current marijuana laws, there is no good reason to stop drug testing for marijuana and risk giving up “valuable information for a handful of people who can impact your workforce and its safety,” according to Ms. Caldwell.

If you missed the live presentation, visit our webinars webpage to view to an on-demand recording and to watch other webinars bought to you by Quest Diagnostics.

Download our Marijuana Legislation by State infographic as a reference guide.

To learn more about marijuana, visit our website or contact us online.

Webinar: Marijuana & the Workplace

January 9, 2017Webinars

Voters passed new measures this election season to allow recreational and medicinal marijuana use in their states, bringing the count to 29 states where cannabis is “legal” in some form. Research also indicates relaxing attitudes towards marijuana and a 2015 Gallup Poll showed that 1 in 4 people have tried the drug. The Quest Diagnostics Drug Testing […]

Read the full article →

Ask the Experts: Getting Started with eCCF

December 21, 2016Webinars

Our recent Gain the eCCF Advantage webinar was well received by many in the drug testing industry. Throughout the presentation, our audience posed a number of questions. Answers to the most frequent and important inquiries from the webinar are provided below as part of our ongoing effort to simplify the complexities of electronic Custody and […]

Read the full article →

Navigating Global Drug Testing Webinar Highlights

December 14, 2016Webinars

Data privacy, drug screen turnaround time, collection network coverage, and logistics form the pillars of an effective international drug testing program. A “one size fits all” approach cannot be taken because factors such as culture, customs, currency, policies, and laws can vary greatly from country to country. In our most recent webinar, our experts offered […]

Read the full article →

Gain the eCCF Advantage Webinar Highlights

November 18, 2016Webinars

In Tuesday’s webinar, experts from Quest Diagnostics shared the benefits of using electronic custody and control forms (eCCF) in federally-regulated drug testing. Charlie Sullivan, Director of Collection Services, and Barbara Rowland, Director of Laboratory Operations, discussed the due diligence it took for Quest to gain HHS National Laboratory Certification Program (NLCP) approval and the impacts […]

Read the full article →

Webinar: Navigating Global Drug Testing

November 10, 2016International testing

Drug use is prevalent throughout the world. According to the 2015 World Drug Report, an estimated 246 million people have used an illicit drug in 2013 and about 27 million people suffer from drug addiction. For that reason, drug testing is crucial for international businesses when hiring new applicants or making decisions about current employees. In the […]

Read the full article →

Gain the eCCF Advantage Webinar

November 4, 2016Webinars

It’s not too late to get the inside scoop on what you need to know to easily integrate eCCF into your drug testing program by attending our upcoming webinar called “Gain the eCCF Advantage.” Join us on Tuesday, November 15 at 1 p.m. CT as Quest Diagnostics drug testing experts, Charlie Sullivan, Director of Collection […]

Read the full article →

Webinar: Gain the eCCF Advantage

October 13, 2016Webinars

With more than 5.8 million federally-regulated urine drug tests conducted in 2015 alone, electronic custody and control forms (eCCF) represents a tremendous opportunity for companies to improve efficiencies to save time on their drug testing programs. While non-regulated eCCFs have been available for several years, Quest Diagnostics will launch eCCF for federally-regulated testing beginning in […]

Read the full article →

Drug Test Toolbox Webinar Highlights

March 31, 2016Webinars

“A drug-free workplace program is a safety program for employees as well as a company’s pledge to protect its customers and assets,” said Lisa Ruehle, Compliance Specialist at Quest Diagnostics, who recently presented the webinar Drug Testing Toolbox. She shared criteria employers should consider when building and maintaining a workplace drug and alcohol testing program. […]

Read the full article →